Elutia
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
20 Firstfield Rd, Gaithersburg, Maryland...Phone Number
(240) 247-1170Website
www.elutia.comRevenue
$12.1 MillionStock Symbol
ELUTIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Elutia
Elutia Inc. is a medicalbiotech company specializing in the development and commercialization of drugeluting biomatrix products that enhance the compatibility of implanted medical devices and support softtissue reconstruction. Elutias proprietary technology combines biologic scaffolds with controlled local drug delivery typically antibiotics enabling its products to support healing while reducing risks like infection, device migration, or poor tissue integration. Among its offerings are biologic envelopes for implantable electronic devices (e.g., pacemakers and defibrillators) under the name EluPro BioEnvelope, as well as a biologic matrix for softtissue reconstruction, SimpliDerm. Following a strategic rebrand (the company was formerly called Aziyo Biologics), Elutia is now fully focused on advancing its drugeluting biomatrix platform across multiple therapeutic areas, including cardiovascular device support, neurostimulation devices, and reconstructive/softtissue surgery.Explore more
Elutia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elutia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Elutia had a recent Job posting/layoffs
Product Launch: Get notified when Elutia launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Elutia has new funding data
Check if Elutia has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Elutia is spiking on competitors!
Elutia, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Elutia recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Elutia
Recommended Actions
Reach out to Masked Content who joined Elutia as Masked Content
Find more new buyers
Compare Similar Companies to Elutia
Compare insights from companies similar to Elutia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Elutia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Elutia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Elutia.
Elutia financials insights
Gather financial insights about Elutia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Debt
$15M
Elutia Tech Stack
A closer look at the technologies used by Elutia
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Open Position
Elutia News & Media
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial LaunchElutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market
Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery MarketElutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026Elutia Signs Definitive Agreement to Sell SimpliDerm® in Transaction Valued at up to $11 Million, Strengthening Balance Sheet Ahead of NXT-41x Launch
Elutia Signs Definitive Agreement to Sell SimpliDerm® in Transaction Valued at up to $11 Million, Strengthening Balance Sheet Ahead of NXT-41x Launch
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Elutia
Sign Up For FreeTo access detailed company insights
Elutia Inc. is a medicalbiotech company specializing in the development and commercialization of drugeluting biomatrix products that enhance the compatibility of implanted medical devices and support softtissue reconstruction. Elutias proprietary technology combines biologic scaffolds with controlled local drug delivery typically antibiotics enabli... Read More
